Skip to main content

9 Result(s)

within E. Cacciari Remove this filter Metabolic Diseases Remove this filter

and

  1. No Access

    Article

    Italian cross-sectional growth charts for height, weight and BMI (2 to 20 yr)

    The aim of this study is to extend to pre-school ages the Italian Society for Pediatric Endocrinology and Diabetes (SIEDP)-2002 growth charts for height, weight and body mass index (BMI), to obtain charts (SIE...

    E. Cacciari, S. Milani, A. Balsamo, E. Spada… in Journal of Endocrinological Investigation (2006)

  2. No Access

    Article

    Final height in a patient with Laron syndrome after long-term therapy with rhIGF-I and short-term therapy with LHRH-analogue and oxandrolone during puberty

    Objective: To report our experience on long-term treatment with recombinant-human-IGF-I (rhIGF-I) of a female patient with Laron syndrome (mutation G223G in the GH receptor gene), who received short-term treat...

    S. Zucchini, E. Scarano, L. Baldazzi… in Journal of Endocrinological Investigation (2005)

  3. No Access

    Article

    Italian cross-sectional growth charts for height, weight and BMI (6–20 y)

    Objective To trace growth charts for height, weight and body mass index (BMI) that apply to the whole Italian population. Different charts were drawn for central-north and south Italy since children in central-no...

    E Cacciari, S Milani, A Balsamo, F Dammacco… in European Journal of Clinical Nutrition (2002)

  4. No Access

    Article

    Indications for a more aggressive disease process in newly diagnosed insulin-dependent diabetic children in Northern than in Southern Europe

    Finland and Sweden have the highest incidence of insulin-dependent diabetes in children in the world, about 3–4 times that of countries in the Mediterranean area, with the exception of Sardinia. We have collec...

    U. Samuelsson, J. Ludvigsson, G. F. Bottazzo, M. Shattock… in Acta Diabetologica (1994)

  5. No Access

    Article

    Long term growth hormone (GH)-releasing hormone and biosynthetic GH therapy in GH-deficient children: comparison of therapeutic effectiveness

    Twenty-five GH-deficient children were treated with GHRH (1-44), once daily sc for 6–24 months. At the 6th month of therapy, 40% of our patients showed a catch-up growth (responded), while the remaining 60% di...

    Dott. M. Bozzola, I. Biscaldi, M. Cisternino… in Journal of Endocrinological Investigation (1990)

  6. No Access

    Article

    Neonatal screening programme for congenital adrenal hyperplasia in a homogenous Caucasian population

    E. Cacciari, A. Balsamo, A. Cassio, S. Piazzi… in Journal of Inherited Metabolic Disease (1986)

  7. No Access

    Article

    Neonatal screening for 21-hydroxylase deficiency: a microfilter paper method for 17-α-hydroxyprogesterone assay

    A micromethod for measuring 17a-hydroxyprogesterone in blo’od collected on filter paper has been developed. Our method is rapid, easy and has the specificity, accuracy and precisoin of the radioimmunoassay in ...

    S. Piazzi, M. Capelli, M. Paolini, D. Perugini… in Journal of Endocrinological Investigation (1982)

  8. No Access

    Article

    HLA genotypes and HLA-linked genetic markers in Italian patients with classical 21-hydroxylase deficiency

    HLA genotype and HLA-linked marker data for 40 unrelated patients from central Italy and 2 unrelated patients from Sardinia with congenital adrenal hyperplasia due to 21-hydroxylase deficiency (21-OH-def) were...

    M. S. Pollack, M. I. New, G. J. O'Neill, L. S. Levine, C. Callaway… in Human Genetics (1981)

  9. No Access

    Article

    Gonadal and adrenal secretion of dehydroepiandrosterone sulfate in prepubertal and pubertal subjects

    The Authors have evaluated the relationship between the secretion of dehydroepiandrosterone sulfate (DHA-S) by the adrenal glands and by the gonads in a group of prepubertal and pubertal subjects (“short norma...

    Dr. Franco Zappulla, D. Ventura, M. Capelli… in Journal of Endocrinological Investigation (1981)